Steris (STE) said Tuesday that a jury trial since December against its Isomedix Operations unit ended in a mistrial on Friday and the court will schedule the case for re-trial.
The mistrial was declared at plaintiff's request during jury deliberations after a juror was dismissed, reducing the jury to fewer than 12 people, the company said.
The case involves allegations by an individual plaintiff that ethylene oxide emissions from a sterilization plant owned and operated by Isomedix from 2005 to 2008 in Waukegan, Illinois, caused personal injury, Steris said.
Shares of Steris were up more than 3% in early trading.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。